The pharmaceutical world is observing a remarkable shift in diabetes management with the emergence of GLP-1 transdermal devices. These systems offer a possibly more convenient alternative to subcutaneous https://elaineuhpl800680.losblogos.com/39727658/glp-1-patches-a-novel-approach-to-blood-sugar-management